Secondary Logo

Journal Logo

August 1995 - Volume 18 - Issue 2
pp: 77-137

PDF Only


The Use of Epstein–Barr Virus–Transformed B Lymphocyte Cell Lines in a Peptide-Reconstitution Assay: Identification of CEA-Related HLA-A*0301–Restricted Potential Cytotoxic T-Lymphocyte Epitopes

Bremers, André J. A.; van der Burg, Sjoerd H.; Kuppen, Peter J. K.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 18(2):77-85, August 1995.


PDF Only


A Phase II Trial of Continuous-Infusion Recombinant Interleukin-2 in Patients with Advanced Renal Cell Carcinoma: A Southwest Oncology Group Study

Whitehead, Robert P.; Wolf, Michael K.; Solanki, Dilip L.; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 18(2):104-114, August 1995.

Phase I Trial of Sequential Cyclophosphamide, Cyclosporin A, and Interferon-α in Patients with Cancer: Attempt to Induce Autologous Graft-Versus-Host Reaction to Elicit an Antitumor Response

Redman, Bruce G.; Chou, Ta-Hsu; Zalupski, Mark; More

Journal of Immunotherapy with Emphasis on Tumor Immunology. 18(2):115-118, August 1995.


Tenth Annual Meeting of the Society for Biological Therapy: PDF Only


Tenth Annual Meeting of the Society for Biological Therapy: PDF Only


Tenth Annual Meeting of Society of Biological Therapy: PDF Only


Show: